Literature DB >> 26567750

Harnessing the alarmin HMGN1 for anticancer therapy.

De Yang1, Michael Bustin2, Joost J Oppenheim1.   

Abstract

Entities:  

Keywords:  G protein-coupled receptor; HMG protein; HMGN1; TLR4; alarmin; antitumor immunity; cancer therapy; chromatin modification; dendritic cell; gene regulation

Mesh：

Substances：

Year:  2015        PMID： 26567750     DOI： 10.2217/imt.15.76

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  4 in total

Review 1.  Alarmins and immunity.

Authors:  Zhen Han; Joost J Oppenheim
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

2.  Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice.

Authors:  Chang-Yu Chen; Satoshi Ueha; Yoshiro Ishiwata; Shoji Yokochi; Joost J Oppenheim; Haru Ogiwara; Shigeyuki Shichino; Shungo Deshimaru; Francis H W Shand; Shiro Shibayama; Kouji Matsushima
Journal:  J Immunother Cancer       Date:  2019-01-29       Impact factor: 13.751

3.  Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice.

Authors:  Zhili Liu; Zhen Lu; Renwei Jing; Bingfeng Zuo; Xianjun Gao; Gang Han; Han Qi; Li Wu; Yunde Liu; Haifang Yin
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

Review 4.  Biological Functions of HMGN Chromosomal Proteins.

Authors:  Ravikanth Nanduri; Takashi Furusawa; Michael Bustin
Journal:  Int J Mol Sci       Date:  2020-01-10       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.